Your search matched 442 results
Mythical Digital | Blog
Is digital healthcare being strong-armed by myths?
The Digital Highway | In The Media
Check out this PharmaTimes article, where Alex Brock, European MD of Omnichannel and Digital at Syneos Health shares his thoughts on the role of digital in pharma.
Digital & Social Strategy | Shared-accelerator
Digital & Social Strategy
On Friday, the Digital Pharma Innovation Day, Joel Sangerman, Chief Commercial Officer for Click Therapeutics, spoke on the topic of “Digital Therapeutics: Software As Treatments.”
According to a study by CapGemini and Quantia MD, the digital experience of healthcare is growing rapidly, especially among new physicians. 2014 is the digital tipping point where Digital Natives outnumber Digital Immigrants.
New physicians are steadily tossing out the paper resources for digital channels.
The Digital & Social Strategy Team recently traveled to Philadelphia to attend the Digital Pharma East conference – the largest event focused exclusively on digital marketing for the life sciences.
This week, the Digital & Social Strategy Team traveled to Philadelphia to attend the Digital Pharma East conference – the largest event focused exclusively on digital marketing for the life sciences.
The Digital Divide | Blog
This digital divide between families with access to broadband and technology and those without, is contributing to inequality across a variety of measures.
Chris Iafolla and I just stepped off the big stage at Digital Pharma East.
Digital therapeutics, or DTx, are distinct from digital health products, and are driven by software programs that can be prescribed to prevent, manage, or treat a medical disorder or disease, as stated by the Digital Therapeutics Alliance.
I had a bit of an epiphany recently when I realized that digital communications, like many of the people who work in our field, is a Millennial and, like other Millennials, is now in its adulthood.
The Digital & Social Strategy team is back at Digital Pharma East for Day 2.
Human Connections in the Digital World | In The Media
What can pharma do to retain human connections in an increasingly digital world?
Malay Gandhi, Managing Director at Rock Health came to Digital Pharma West to help us see the future through the changing investments of big digital health backers.
At this year’s Digital Medicine & MedTech Showcase (part of Biotech Showcase), a panel of digital therapeutics (DTx) experts illuminated the status and future of their work, moderated by Syneos Health Commercial Solutions Chief Strategy Officer, Baba Shetty.
It’s estimated that 37% of the world’s population are digitally excluded.
With there being so many different stakeholders, including patients, providers and payers, panelists at the 2019 Digital Medicine & MedTech Showcase pointed to a number of different adoption roadblocks—and successes.
The answer, it seems, is neither yes nor no, and the panelists at 2019 Digital Medicine and MedTech showcase weighed in from a number of different perspectives.
Following just a few years after its 2016 digital health research report, the American Medical Association’s most recent study of the use and adoption of digital clinical tools is proving that more and more physicians are becoming increasingly open to emerging technology.
We’re just a few years away from digital therapies taking on traditional medicines on their own turf: clinical trials, formularies, and prescription pads.
This year our digital trendspotters are looking at eight trends set to change how healthcare marketers connect with people.
Digital Therapeutics Grow Up | Perspectives
Digital therapeutics have been hailed as a game-changer for pharma and patients, but are they keeping up with the hype?
It's Time for a Digital Reset | Perspectives
What should the evolution of your digital strategy look like through COVID-19 and beyond?
The Syneos Health Podcast: Digital Therapeutics | Perspectives
Our team discusses the digital therapeutics landscape, the opportunities for both biopharma and tech companies, regulatory and payer hurdles, and more.
GSW’s third report of their 4-part annual trends series: Digital Trends.
In this podcast our team discusses the digital therapeutics landscape, the opportunities for both biopharma and tech companies, regulatory and payer hurdles, and more.
Domino’s has a history of leveraging digital technology to make pizza more exciting.
For the first time digital media spend numbers were made available via Kantar Media.
eMarketer’s latest numbers on Pharma’s digital ad spend are in, and the word of the day is growth.